Featured post

SCS research and awards news

For all our research and awards news, please visit our news page.

Monday 17 July 2017

Nilotinib dose-optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENESTxtnd

Jake Shortt et al. published in the British Journal of Haematology.

Read article here.

No comments:

Post a Comment